+1 Recommend
    • Review: found
    Is Open Access

    Review of 'Biventricular Arrhythmogenic Cardiomyopathy: a paradigmatic case'

    Biventricular Arrhythmogenic Cardiomyopathy: a paradigmatic caseCrossref
    Helpful for the clinical practice of cardiology.
    Average rating:
        Rated 4 of 5.
    Level of importance:
        Rated 4 of 5.
    Level of validity:
        Rated 3 of 5.
    Level of completeness:
        Rated 4 of 5.
    Level of comprehensibility:
        Rated 4 of 5.
    Competing interests:

    Reviewed article

    • Record: found
    • Abstract: found
    • Article: found
    Is Open Access

    Biventricular Arrhythmogenic Cardiomyopathy: a paradigmatic case

    We present a case of arrhythmogenic cardiomyopathy with biventricular involvement and strong arrhythmic substrate, highlighting the need to consider more than a single diagnostic option when facing arrhythmic presentations in young patients and the growing contribution provided by the genetic laboratory and contrast CMR to clinical management.

      Review information

      This work has been published open access under Creative Commons Attribution License CC BY 4.0, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Conditions, terms of use and publishing policy can be found at www.scienceopen.com.

      Sudden death,Cardiac magnetic resonance,Ventricular tachycardia,Desmoplakin,Arrhythmogenic Cardiomyopathy,Syncope,ARVC

      Review text

      In this manuscript, M. Calcagnino et al report a rare case of biventricular arrhythmogenic cardiomyopathy. They emphasize the importance of cardiac magnetic resonance and genetic testing for correct diagnosis. The paper is helpful for the clinical practice of cardiology.

      I have the following remarks:

      A. The auxiliary examination results of the case are comprehensive. However, some vital medical history (eg. alcohol consumption, diabetes etc) and physical examination records should be noted.

      B. Since the patient was started on Sotalol 80 mg t.i.d., He was stable and PVCs were reduced. If possible, changes about echocardiography (eg. Two chamber size and EF ) at clinical follow-ups should be mentioned.

      C. What’s the opinion of the authors about the criteria of biventricular arrhythmogenic cardiomyopathy?

      D. Abbreviations should be defined within the text at first use.


      Comment on this review

      Version and Review History